Warning: The NCBI web site requires JavaScript to function. more...
Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis.
Lewis-Wambi JS, Kim HR, Wambi C, Patel R, Pyle JR, Klein-Szanto AJ, Jordan VC.
Breast Cancer Res. 2008;10(6):R104. Epub 2008 Dec 5.
Related citations
Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation.
Lewis JS, Meeke K, Osipo C, Ross EA, Kidawi N, Li T, Bell E, Chandel NS, Jordan VC.
J Natl Cancer Inst. 2005 Dec 7;97(23):1746-59.
Potential of l-buthionine sulfoximine to enhance the apoptotic action of estradiol to reverse acquired antihormonal resistance in metastatic breast cancer.
Lewis-Wambi JS, Swaby R, Kim H, Jordan VC.
J Steroid Biochem Mol Biol. 2009 Mar;114(1-2):33-9. Epub 2009 Jan 9.
Apoptotic action of 17beta-estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivo.
Liu H, Lee ES, Gajdos C, Pearce ST, Chen B, Osipo C, Loweth J, McKian K, De Los Reyes A, Wing L, Jordan VC.
J Natl Cancer Inst. 2003 Nov 5;95(21):1586-97.
Decreased glutathione levels potentiate the apoptotic efficacy of selenium: possible involvement of p38 and JNK MAPKs--in vitro studies.
Ranawat P, Bansal MP.
Mol Cell Biochem. 2008 Feb;309(1-2):21-32. Epub 2007 Nov 8.
[The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX, Kong CZ.
Zhonghua Yi Xue Za Zhi. 2008 Jan 22;88(4):271-5. Chinese.
Estrogen-induced apoptosis in a breast cancer model resistant to long-term estrogen withdrawal.
Lewis JS, Osipo C, Meeke K, Jordan VC.
J Steroid Biochem Mol Biol. 2005 Feb;94(1-3):131-41. Epub 2005 Feb 8.
Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
Kim R, Tanabe K, Emi M, Uchida Y, Osaki A, Toge T.
Int J Oncol. 2005 Apr;26(4):1025-31.
Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells.
Teixeira C, Reed JC, Pratt MA.
Cancer Res. 1995 Sep 1;55(17):3902-7.
Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins.
Gautschi O, Tschopp S, Olie RA, Leech SH, Simões-Wüst AP, Ziegler A, Baumann B, Odermatt B, Hall J, Stahel RA, Zangemeister-Wittke U.
J Natl Cancer Inst. 2001 Mar 21;93(6):463-71.
Comparison of possible carcinogenic estradiol metabolites: effects on proliferation, apoptosis and metastasis of human breast cancer cells.
Seeger H, Wallwiener D, Kraemer E, Mueck AO.
Maturitas. 2006 Apr 20;54(1):72-7. Epub 2005 Oct 4.
Novel antitumor effect of estradiol in athymic mice injected with a T47D breast cancer cell line overexpressing protein kinase Calpha.
Chisamore MJ, Ahmed Y, Bentrem DJ, Jordan VC, Tonetti DA.
Clin Cancer Res. 2001 Oct;7(10):3156-65.
Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol.
Song RX, Mor G, Naftolin F, McPherson RA, Song J, Zhang Z, Yue W, Wang J, Santen RJ.
J Natl Cancer Inst. 2001 Nov 21;93(22):1714-23.
Altered subcellular localization of p53 in estrogen-dependent and estrogen-independent breast cancer cells.
Lilling G, Nordenberg J, Rotter V, Goldfinger N, Peller S, Sidi Y.
Cancer Invest. 2002;20(4):509-17.
Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL, Sugimoto Y, Liu S, Ye W, Wang LS, Huang YW, Lin YC.
Anticancer Res. 2006 May-Jun;26(3A):1773-84.
Estrogen regulates Bcl-w and Bim expression: role in protection against beta-amyloid peptide-induced neuronal death.
Yao M, Nguyen TV, Pike CJ.
J Neurosci. 2007 Feb 7;27(6):1422-33.
Development of resistance to glutathione depletion-induced cell death in CC531 colon carcinoma cells: association with increased expression of bcl-2.
Vahrmeijer AL, Hoetelmans RW, Mulder GJ, Schutrups J, van Vlierberghe RL, van de Velde CJ, van Dierendonck JH.
Biochem Pharmacol. 2000 Jun 15;59(12):1557-62.
Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
Menendez JA, Vellon L, Colomer R, Lupu R.
Int J Cancer. 2005 May 20;115(1):19-35.
ZD1839 (IRESSA), an EGFR-selective tyrosine kinase inhibitor, enhances taxane activity in bcl-2 overexpressing, multidrug-resistant MCF-7 ADR human breast cancer cells.
Ciardiello F, Caputo R, Borriello G, Del Bufalo D, Biroccio A, Zupi G, Bianco AR, Tortora G.
Int J Cancer. 2002 Mar 20;98(3):463-9.
Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells.
Huang Y, Ray S, Reed JC, Ibrado AM, Tang C, Nawabi A, Bhalla K.
Breast Cancer Res Treat. 1997 Jan;42(1):73-81.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on